Skip to main content
Clinical Trials/NCT03016390
NCT03016390UnknownNot Applicable

Electromagnetic Interference and Automobile Remote Keyless Entry in Cardiovascular Implantable Electronic Device (CIED) Patients

Chiang Mai University0 sites100 target enrollmentStarted: April 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
100
Primary Endpoint
Incidence of any Electromagnetic interference

Study Overview

Brief Summary

Cardiovascular Implantable Electronic device (CIED) is a evolution therapy and number of patients with it are growing rapidly. Electromagnetic interference causing device malfunction is not uncommon, Radiofrequency Identification system is among its plausible source. Patients with CIEDs are at risk of exposure to this novel product in their daily living especially automobile keyless access system. Only informal studies have been conducted and not be published. Formal and systemic evaluation and tests are crucial.

Study Design

Study Type
Observational
Observational Model
Case Crossover
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age more than 18 years old
  • Able to give informed consent
  • Implanted with functioning pacemakers or AICD more than 3 months
  • Adequate and stable all device parameters
  • Able to operate self triggering event recorders (at least 30 seconds)

Exclusion Criteria

  • Patient with single chamber (Atrial) pacemaker (AAI or AAIR)
  • Presence of unstable hemodynamic or conditions
  • Presence of sustained or ongoing arrhythmia, besides atrial fibrillation/atrial flutter in single (ventricle) chamber device or Atrio-ventricular block
  • Documented of over-sensing episodes under regular sensitivity threshold (0.25 mV or more in the atrial channel and 0.75 mV or more in the ventricular channel, for permanent pacemaker device, and manufacture default setting in Automatic Implantable Cardioverter-Defibrillator, AICD)
  • Lack of noise oversensing detection/trigger and Electrogram (EGM) storage capability
  • Lack of tachyarrhythmia detection and episode storage capability

Outcomes

Primary Outcomes

Incidence of any Electromagnetic interference

Time Frame: Immediately after completion of the protocol test

Secondary Outcomes

  • Incidence of pacing inhibition in ventricular channel(Immediately after completion of the protocol test)
  • Incidence of noise reversion(Immediately after completion of the protocol test)
  • Incidence of ventricular tachycardia/fibrillation detection(Immediately after completion of the protocol test)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Narawudt Prasertwitayakij

lecturer

Chiang Mai University

Similar Trials

Electromagnetic Interference and... | Clinical Trial